ROVI: JAPAN SUSPENDS VACCINES PRODUCED BY ROVI AFTER CONTAMINANTS FOUND (ANÁLISIS BANCO SABADELL)
ROVI is falling -12% in absolute terms (-11% vs. IBEX) following press reports suggesting that Japan would have withdrawn a batch of 1.63 M Moderna vaccines after contaminants were found in some vials that would have been bottled by the Spanish company (which has not yet made any official statements).Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.